Kevin Rosenblatt MD, PhD

Dr. Kevin P. Rosenblatt is a distinguished physician-scientist renowned for his expertise in molecular pathology and clinical proteomics. He holds a dual degree from the University of Texas Southwestern Medical School and Graduate School for Biomedical Sciences, complemented by a fellowship at the National Cancer Institute. Dr. Rosenblatt’s academic tenure includes roles as Adjunct Associate Professor at the University of Texas McGovern Medical School and MD Anderson Cancer Center, where he mentored in molecular biology and directed proteomics research. His entrepreneurial ventures, including founding roles at Consultative Genomics and NX Prenatal, highlight his leadership in advancing genetic diagnostics and personalized medicine. Currently, he serves as Laboratory Director at ImmunoGenomics, driving innovation in molecular diagnostics and healthcare solutions through KPR ScientificHealth.

For over two decades, Dr. Rosenblatt has seamlessly integrated research and clinical practice, pioneering new diagnostic technologies and directing clinical laboratories across various medical institutions. His dedication to advancing precision medicine and molecular diagnostics underscores his commitment to improving patient care and shaping the future of healthcare.